Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03045328
Title Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Steven E. Coutre
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.